porcin
reproduct
respiratori
syndrom
viru
prrsv
econom
import
swine
pathogen
sinc
discoveri
earli
tremend
progress
made
understand
molecular
biolog
pathogenesi
prrsv
although
modifi
liveattenu
vaccin
mlv
inactiv
vaccin
prrsv
avail
decad
diseas
remain
difficult
control
efficaci
vaccin
especi
heterolog
strain
remain
question
mlv
gener
effect
homolog
strain
variabl
success
heterolog
strain
outcom
inactiv
vaccin
field
promis
develop
prrsv
revers
genet
system
acquisit
new
understand
antiprrsv
immun
ration
design
next
gener
prrsv
vaccin
explor
review
discuss
recent
advanc
antiprrsv
immun
vaccinolog
recent
progress
prrsv
vaccin
develop
particularli
revers
genet
systembas
vaccin
develop
provid
perspect
potenti
novel
strategi
approach
may
applic
develop
next
gener
prrsv
vaccin
porcin
reproduct
respiratori
syndrom
prr
econom
import
diseas
character
reproduct
failur
sow
respiratori
diseas
pig
age
botner
done
paton
pig
suffer
diseas
first
manifest
acut
ill
includ
anorexia
lethargi
sometim
pyrexia
dyspnea
cyanosi
extrem
reproduct
failur
sow
includ
stillbirth
mummif
see
front
matter
elsevi
bv
right
reserv
weak
born
piglet
high
prewean
mortal
occur
concurr
soon
acut
ill
mengel
et
al
meulenberg
rowland
caus
agent
prr
porcin
reproduct
respiratori
syndrom
viru
prrsv
envelop
singlestrand
positivesens
rna
viru
collin
et
al
dea
et
al
meulenberg
wensvoort
et
al
prrsv
belong
famili
arterivirida
order
nidoviral
includ
member
coronavirida
ronivirida
famili
gorbalenya
et
al
famili
arterivirida
also
compris
three
virus
equin
arter
viru
eav
simian
hemorrhag
fever
viru
shfv
lactat
dehydrogenas
elev
viru
ldv
member
arterivirida
famili
distinct
host
rang
viru
pig
prrsv
hors
donkey
eav
monkey
shfv
mice
ldv
snijder
meulenberg
four
virus
target
macrophag
respect
host
infect
two
receptor
porcin
alveolar
macrophag
pam
porcin
sialoadhesin
identifi
prrsv
entri
uncoat
respect
van
gorp
et
al
vanderheijden
et
al
prrsv
isol
divid
two
distinct
genotyp
european
type
north
american
type
ii
meng
et
al
two
genotyp
prrsv
caus
diseas
symptom
antigen
differ
kapur
et
al
meng
et
al
meng
meulenberg
nelsen
et
al
ropp
et
al
stadejek
et
al
prrsv
genom
approxim
kb
length
consist
untransl
region
utr
nine
open
read
frame
orf
follow
utr
poli
tail
dea
et
al
meng
et
al
meng
locat
proxim
part
consist
approxim
genom
encod
put
nonstructur
protein
nsp
cleav
proteolyt
process
meulenberg
et
al
snijder
meulenberg
ziebuhr
et
al
main
proteinas
serin
proteinas
mediat
nsp
process
ziebuhr
et
al
cleavag
junction
confirm
tian
et
al
three
accessori
cystein
proteinas
respons
autocatalyt
process
singl
cleav
site
den
boon
et
al
ziebuhr
et
al
contain
sever
immunodomin
bcell
epitop
dispens
viru
replic
somehow
modul
host
immun
respons
chen
et
al
oleksiewicz
et
al
nsp
compris
put
domain
viral
rnadepend
rna
polymeras
rdrp
helicas
bautista
et
al
uridylatespecif
endoribonucleas
nendou
respect
nedialkova
et
al
snijder
meulenberg
function
activ
helicas
nendou
prrsv
experiment
verifi
bautista
et
al
nedialkova
et
al
recent
shown
inhibit
activ
interferon
beta
promot
differ
intens
indic
prrsv
nsp
abl
subvert
host
innat
immun
attenu
type
ifn
respons
beura
et
al
chen
et
al
proxim
part
genom
encod
seven
prrsv
structur
protein
translat
cotermin
nest
set
six
subgenom
mrna
meng
et
al
meulenberg
et
al
encod
four
membraneassoci
nglycosyl
protein
wherea
encod
two
nonglycosyl
membran
protein
e
dea
et
al
meulenberg
et
al
last
orf
encod
nucleocapsid
protein
n
encapsid
viral
rna
genom
spilman
et
al
protein
abund
envelop
glycoprotein
contain
major
neutraliz
epitop
ostrowski
et
al
pirzadeh
dea
plagemann
b
plagemann
et
al
protein
form
disulfidelink
heterodim
serv
ligand
prrsv
intern
receptor
alveolar
macrophag
van
breedam
et
al
recent
interact
three
minor
envelop
glycoprotein
also
detect
coimmunoprecipit
assay
da
et
al
form
heterotrim
complex
requir
assembl
infecti
prrsv
virion
wissink
et
al
found
interact
prrsv
receptor
da
et
al
overal
recent
find
prrsv
nonstructur
structur
protein
provid
new
insight
prrsv
biolog
vaccin
develop
sinc
recognit
late
prr
devast
swine
industri
worldwid
prr
outbreak
frequent
occur
worldwid
caus
tremend
econom
loss
recent
exampl
emerg
variant
strain
prrsv
associ
porcin
high
fever
syndrom
phf
china
tian
et
al
result
signific
econom
loss
china
vietnam
unit
state
alon
estim
annual
loss
associ
prrsv
reach
half
billion
dollar
neumann
et
al
two
type
commerci
vaccin
current
avail
prrsv
modifi
liveattenu
vaccin
mlv
inactiv
vaccin
kimman
et
al
mlv
prrsv
becam
avail
gener
effect
homolog
strain
variabl
success
less
effect
sometim
ineffect
heterolog
strain
current
mlv
associ
numer
problem
shed
vaccin
viru
persist
infect
incomplet
protect
revers
virul
exampl
acut
prr
outbreak
occur
danish
herd
vaccin
mlv
outbreak
link
revers
vaccin
viru
pathogen
phenotyp
storgaard
et
al
vaccinederiv
prrsv
strain
isol
nonsymptomat
persistentlyinfect
pig
key
et
al
key
et
al
zimmerman
et
al
mlv
vaccinederiv
isol
found
caus
diseas
experimentallyinfect
pig
opriessnig
et
al
mlv
deriv
singl
prrsv
vaccin
strain
fulli
protect
pig
heterolog
prrsv
infect
kimman
et
al
labarqu
et
al
commerci
inactiv
vaccin
except
farmspecif
autogen
product
avail
unit
state
outcom
use
inactiv
vaccin
countri
promis
given
degre
genet
divers
observ
among
prrsv
strain
unlik
vaccin
base
singl
strain
confer
effect
protect
antigen
genet
diversifi
field
strain
current
circul
swine
herd
worldwid
effect
vaccin
heterolog
strain
larg
depend
antigen
genet
related
viru
strain
vaccin
anim
expos
observ
genet
divers
among
field
isol
continu
major
obstacl
prr
control
therefor
design
futur
vaccin
must
take
antigen
genet
divers
prrsv
consider
prr
remain
difficult
control
articl
first
review
recent
advanc
antiprrsv
immun
vaccinolog
depth
review
prrsv
biolog
pathogenesi
found
elsewher
kimman
et
al
lopez
osorio
mateu
diaz
murtaugh
et
al
discuss
recent
progress
prrsv
vaccin
develop
particularli
use
revers
genet
system
prrsv
vaccin
develop
final
provid
perspect
potenti
novel
strategi
approach
may
applic
develop
next
gener
prrsv
vaccin
prrsvinfect
pig
surviv
acut
stage
infect
last
month
usual
develop
persist
infect
low
level
viral
load
time
complet
prrsv
clearanc
estim
least
day
beyond
market
lifetim
pig
allend
et
al
although
mechan
underli
failur
promptli
clear
prrsv
infect
poorli
understood
appear
major
reason
inabl
pig
develop
effect
protect
immun
respons
lunney
et
al
mateu
diaz
demonstr
prrsv
neutral
antibodi
play
critic
role
clearanc
viru
abl
complet
protect
pig
prrsv
reinfect
lopez
osorio
murtaugh
et
al
osorio
et
al
howev
neutral
antibodi
major
structur
compon
appear
later
nonneutr
antibodi
induc
structur
protein
prrsv
infect
consequ
infect
pig
effici
resolv
viru
infect
earli
phase
lopez
osorio
three
possibl
explan
delay
appear
neutral
antibodi
first
contain
immunodomin
epitop
epitop
decoy
epitop
ectodomain
induc
earli
strong
nonneutr
immun
respons
diminish
mask
immun
respons
elicit
downstream
nearbi
neutral
epitop
epitop
b
ostrowski
et
al
yang
et
al
secondli
exist
high
mannos
glycan
nlink
glycosyl
site
flank
epitop
b
diminish
sensit
prrsv
virion
neutral
antibodi
thu
impair
immunogen
nearbi
epitop
b
faaberg
et
al
plagemann
et
al
thirdli
prrsv
employ
variou
strategi
inhibit
initi
innat
immun
respons
particular
product
type
ifn
subsequ
dampen
host
adapt
immun
respons
includ
humor
immun
respons
mateu
diaz
murtaugh
et
al
royae
et
al
therefor
ideal
prrsv
vaccin
abl
induc
rapid
robust
respons
neutral
antibodi
without
suppress
antiprrsv
innat
immun
dendrit
cell
dc
profession
antigenpres
cell
apc
locat
throughout
peripher
immun
system
play
critic
role
link
innat
detect
captur
viru
induct
adapt
immun
respons
palucka
banchereau
invad
foreign
pathogen
trigger
migrat
immatur
dc
blood
tissu
detect
captur
pathogen
activ
dc
uptak
pathogen
antigen
process
immunogen
peptid
mhc
molecul
present
cell
banchereau
steinman
mani
virus
caus
persist
infect
human
immunodefici
viru
hiv
hepat
b
viru
hbv
hepat
c
viru
hcv
exploit
elimin
dc
function
evad
innat
adapt
immun
liu
et
al
exampl
dc
serv
trojan
hors
effici
sequest
hiv
transfer
hiv
target
cell
thu
facilit
persist
viru
transmiss
wu
kewalramani
process
mediat
interact
hiv
protein
ctype
lectin
dcsign
dendrit
cellspecif
intercellular
adhes
nonintegrin
dc
van
kooyk
geijtenbeek
whether
prrsv
target
porcin
dc
exercis
immun
evas
strategi
may
understudi
current
research
prrsv
dc
interact
mainli
focus
whether
product
interferon
specif
inflammatori
cytokin
dc
may
activ
prime
differenti
distinct
type
cell
downor
upregul
respons
prrsv
exposur
plasmacytoid
dc
pdc
consid
key
effector
dc
express
high
level
type
ifn
earli
antivir
innat
immun
gilliet
et
al
recent
use
novel
fluorescentactiv
cell
sort
procedur
porcin
pdc
character
high
low
phenotyp
isol
porcin
peripher
blood
mononuclear
cell
pbmc
calzadanova
et
al
shown
porcin
pdc
expos
prrsv
vitro
secret
calzadanova
et
al
prrsv
also
appear
capabl
infect
porcin
myeloid
dc
mdc
includ
bone
marrowderiv
dc
bmdc
monocytederiv
dc
mddc
vitro
alter
express
level
variou
cytokin
cd
marker
specul
contribut
suppress
antiprrsv
protect
immun
respons
chang
et
al
charerntantanakul
et
al
floresmendoza
et
al
love
et
al
wang
et
al
addit
porcin
dcsign
pdcsign
gene
recent
clone
vitro
cultur
mddc
found
enhanc
vitro
transmiss
prrsv
target
cell
huang
et
al
interest
see
whether
pdcsign
function
attach
receptor
specif
subset
porcin
dc
dissemin
prrsv
cours
infect
vivo
aid
design
novel
strategi
vaccin
effici
modul
pig
immun
system
prrsv
infect
futur
studi
warrant
identifi
dissect
distinct
signal
pathway
molecul
well
relev
viral
compon
involv
interplay
dc
prrsv
investig
role
dc
facilit
prrsv
transmiss
regulatori
cell
treg
character
phenotyp
also
crucial
player
balanc
innat
adapt
immun
respons
sakaguchi
et
al
adapt
induc
treg
induc
dcspresent
microbi
antigen
secret
high
amount
suppress
excess
inflammatori
respons
thu
reduc
damag
host
tissu
sakaguchi
et
al
howev
mani
pathogen
includ
hiv
hcv
hbv
also
exploit
induc
treg
subvert
protect
immun
respons
allow
establish
persist
infect
belkaid
recent
two
studi
independ
show
porcin
induc
treg
inde
induc
cocultur
porcin
mddc
expos
type
ii
prrsv
vitro
indic
increas
number
cell
enhanc
express
mrna
silvacampa
et
al
wongyanin
et
al
induc
treg
display
suppress
activ
phastimul
pbmc
moreov
express
mrna
protein
upregul
cocultur
cell
infect
prrsv
indic
prrsvinduc
treg
belong
helper
subset
silvacampa
et
al
interestingli
use
experiment
protocol
treg
induc
type
prrsvinfect
mddc
suggest
prrsvinduc
respons
may
typeor
straindepend
least
vitro
silvacampa
et
al
find
may
provid
basi
potenti
strategi
improv
prrsv
vaccin
efficaci
inhibit
prrsvinduc
treg
activ
howev
whether
prrsv
infect
prime
treg
activ
lead
immunosuppress
pig
vivo
remain
determin
futur
studi
major
obstacl
develop
effect
prrsv
vaccin
prrsv
util
differ
mean
subvert
host
immun
respons
later
stage
infect
due
low
fidel
viral
rdrp
mutat
introduc
prrsv
genom
result
exist
antigen
heterogen
epitop
recogn
neutral
antibodi
cell
lead
escap
host
immun
surveil
make
difficult
host
gener
protect
immun
respons
elimin
viru
especi
heterolog
strain
meng
addit
prrsvinfect
pam
may
sequest
viru
viral
protein
express
plasma
membran
make
viral
inform
becom
invis
host
immun
system
consequ
infect
cell
refractori
antibodydepend
complementmedi
lysi
coster
et
al
reason
hypothes
discuss
host
nonor
semipermiss
cell
pdc
mdc
like
similar
properti
help
prrsv
remain
persist
state
one
unusu
characterist
prrsvinduc
immun
prrsvspecif
antibodi
matern
origin
confer
vaccin
facilit
entri
viru
target
cell
lead
increas
infect
yoon
et
al
yoon
et
al
phenomenon
known
antibodydepend
enhanc
ade
viral
infect
also
consid
obstacl
prrsv
vaccin
develop
although
underli
mechan
remain
elus
christianson
et
al
shibata
et
al
tirado
yoon
recent
studi
ade
mechan
rna
virus
suggest
addit
enhanc
viral
uptak
ade
may
suppress
innat
antivir
respons
especi
type
ifn
system
host
mahalingam
lidburi
moreov
ade
enabl
virus
benefit
antiinflammatori
immunosuppress
environ
creat
autocrin
paracrin
product
berlato
et
al
ito
et
al
mahalingam
lidburi
sinc
product
significantli
increas
bronchoalveolar
lavag
fluid
prrsvinfect
pig
thanawongnuwech
et
al
specul
cours
ade
prrsv
infect
stronger
upregul
would
occur
pam
may
contribut
downregul
product
inflammatori
cytokin
therefor
attenu
elimin
neg
effect
ade
may
induc
vaccin
consid
key
factor
novel
prrsv
vaccin
develop
experiment
subunit
vaccin
system
base
upon
plasmid
dna
bacteria
baculoviru
adenoviru
fowlpox
viru
pseudorabi
viru
carri
sever
prrsv
antigen
includ
andor
develop
evalu
prrsv
jiang
et
al
jiang
et
al
jiang
et
al
jiang
et
al
shen
et
al
case
anim
immun
togeth
antigen
develop
higher
titer
neutral
antibodi
prrsv
produc
stronger
lymphocyt
prolifer
respons
compar
anim
immun
alon
remain
seen
whether
subunit
vaccin
better
exist
mlv
kill
product
revers
genet
system
defin
gener
virus
possess
genom
deriv
clone
cdna
infecti
clone
boyer
haenni
provid
power
tool
dissect
role
viral
protein
viru
life
cycl
pathogen
also
open
door
develop
liveattenu
viru
vaccin
introduc
attenu
mutat
viral
genom
effici
humor
cellular
immun
engin
viru
induc
increas
likelihood
protect
viral
diseas
neumann
et
al
vaccin
design
stabl
safer
convent
liveattenu
virus
gener
continu
blind
cell
passag
major
limit
develop
effect
subunit
vaccin
revers
geneticsbas
mlv
heterogen
natur
prrsv
strain
worldwid
current
experiment
subunit
vaccin
revers
geneticsbas
mlv
mostli
base
upon
singl
strain
prrsv
remain
doubt
vaccin
provid
suffici
level
heterolog
protect
field
first
revers
genet
system
european
genotyp
lelystad
viru
north
american
genotyp
strain
prrsv
rnalaunch
use
lowcopynumb
dna
plasmid
clone
vector
templat
gener
vitro
rna
transcript
directli
transfect
suscept
cell
recov
viru
nielsen
et
al
promot
insert
immedi
upstream
fulllength
viral
genom
cdna
drive
vitro
transcript
reaction
choi
et
al
nielsen
et
al
rnalaunch
system
report
recov
genotyp
prrsv
differ
geograph
origin
wide
use
function
studi
viral
gene
lv
et
al
truong
et
al
yoo
et
al
zhou
et
al
dnalaunch
revers
genet
system
report
recov
type
ii
prrsv
strain
direct
transfect
cell
fulllength
viral
genom
cdna
clone
cytomegaloviru
cmv
promot
recogn
cellular
rna
polymeras
ii
lee
et
al
dnalaunch
system
could
improv
introduct
selfcleav
ribozym
element
termini
viral
genom
cdna
expect
retain
authent
termin
nucleotid
sequenc
viral
genom
huang
et
al
rescu
efficaci
type
prrsv
strain
express
gfp
system
approxim
higher
rnalaunch
system
tradit
dnalaunch
system
without
engin
ribozym
element
determin
report
gfp
level
transfect
cell
peak
titer
recoveri
viru
huang
et
al
improv
revers
genet
system
also
appli
rescu
type
ii
prrsv
strain
higher
efficaci
ni
et
al
unpublish
data
avail
improv
dnalaunch
system
futur
product
seed
viru
stock
revers
geneticsbas
mlv
reduc
cost
time
bypass
need
rna
invitrotranscript
step
understand
molecular
basi
prrsv
virul
critic
gener
attenu
prrsv
vaccin
seri
prrsv
infecti
cdna
clone
construct
specif
genom
region
attenu
type
ii
prrsv
vaccin
strain
prime
pac
systemat
swap
counterpart
backbon
highli
virul
infecti
cdna
clone
prrsv
kwon
et
al
truong
et
al
transfect
respect
chimer
construct
cell
result
rescu
viabl
virus
pregnant
sow
inocul
chimer
virus
along
day
gestat
viabil
offspr
birth
wean
evalu
result
show
virul
determin
possibl
locat
nsp
except
structur
orf
confirm
multigen
charact
prrsv
virul
deduc
sequenc
comparison
particular
appear
compris
major
virul
determin
wherea
virul
determin
may
resid
kwon
et
al
addit
chimer
virus
use
infect
pam
vitro
assess
genet
determin
affect
host
immun
respons
identifi
play
regulatori
role
gudmundsdottir
risatti
similar
studi
also
conduct
use
chimer
prrsv
infecti
cdna
clone
deriv
two
distinct
type
ii
prrsv
strain
attenu
ingelvac
prr
mlv
virul
strain
two
reciproc
chimer
cdna
clone
region
one
genom
fuse
utr
genom
display
similar
antibodi
respons
two
parent
virus
much
less
sever
pathogen
compar
group
indic
virul
determin
present
throughout
viral
genom
two
reciproc
chimer
virus
well
chimera
encod
strain
clone
backbon
ingelvac
prr
mlv
abl
protect
pig
challeng
two
heterolog
strain
respect
ellingson
et
al
wang
et
al
result
suggest
mlv
base
backbon
tradit
cell
cultureattenu
vaccin
strain
develop
futur
use
chimer
infecti
cdna
clone
moreov
appear
simpl
exchang
region
field
strain
could
provid
improv
vaccin
efficaci
heterolog
protect
interest
see
whether
chimer
construct
type
type
ii
prrsv
rescu
recombin
virus
disadvantag
current
prrsv
mlv
pig
vaccin
mlv
distinguish
naturallyinfect
field
strain
prrsv
serolog
assay
gener
marker
diva
differenti
infect
vaccin
anim
prrsv
vaccin
base
delet
marker
ie
immunogen
marker
absent
vaccin
strain
present
field
strain
viral
genom
revers
genet
system
allow
differenti
great
valu
control
eventu
elimin
prrsv
candid
gene
use
gener
delet
marker
sinc
appear
toler
larg
delet
associ
sever
immunodomin
bcell
epitop
type
type
ii
prrsv
genom
chen
et
al
kim
et
al
oleksiewicz
et
al
de
lima
et
al
demonstr
prrsv
mutant
lack
immunodomin
bcell
linear
epitop
within
gene
deriv
type
ii
prrsv
viabl
vitro
infect
pig
de
lima
et
al
de
lima
et
al
mutant
also
display
effici
growth
vitro
vivo
induc
n
proteinspecif
serum
antibodi
delet
epitopespecif
antibodi
measur
epitop
peptidebas
elisa
fifteen
inocul
pregnant
sow
mutant
viru
parent
wildtyp
viru
produc
similar
virul
phenotyp
pregnant
sow
model
assess
prrsv
challeng
pregnant
sow
gestat
measur
viabil
offspr
birth
upon
wean
day
age
result
indic
delet
marker
epitop
contribut
attenu
mutant
viru
de
lima
et
al
anoth
proofofprincipl
studi
recombin
type
prrsv
strain
express
gfp
delet
immunogen
epitop
within
gene
use
marker
vaccin
candid
nurseri
pig
diseas
model
fang
et
al
antin
protein
antibodi
respons
pig
inocul
mutant
viru
reach
similar
level
parent
recombin
viru
day
postimmun
measur
commerci
elisa
kit
howev
compar
parent
viru
mutant
viru
express
gfp
appear
attenu
evidenc
presenc
lower
level
viremia
use
gfpand
epitopespecif
elisa
shown
pig
immun
mutant
viru
develop
antibodi
delet
epitop
develop
highlevel
antibodi
respons
gfp
day
postinfect
stabil
introduc
marker
region
potenti
concern
kim
et
al
demonstr
enhanc
green
fluoresc
protein
egfp
insert
region
egfpcontain
genom
properli
express
produc
viru
although
egfp
fluoresc
lost
passag
recombin
egfp
virus
cultur
indic
introduc
marker
region
genet
stabl
nevertheless
result
suggest
possibl
develop
doublemark
mlv
contain
posit
gfp
neg
delet
epitop
marker
allow
serolog
differenti
vaccin
pig
infect
field
strain
alon
coinfect
mlv
field
strain
fang
et
al
amino
acid
sequenc
analysi
epitop
region
reveal
contain
seven
small
bcell
epitop
two
highli
conserv
among
type
prrsv
strain
known
sequenc
accordingli
antibodi
could
detect
serum
sampl
pig
infect
four
repres
field
strain
type
prrsv
measur
epitopespecif
elisa
fang
et
al
suggest
epitopedelet
mutant
could
use
prrsv
marker
vaccin
distinguish
type
prrsv
strain
howev
sinc
epitop
conserv
type
type
ii
prrsv
react
serum
sampl
pig
infect
type
ii
isol
inde
comparison
identifi
bcell
epitop
reveal
none
epitop
conserv
type
type
ii
prrsv
isol
de
lima
et
al
oleksiewicz
et
al
therefor
appear
type
type
ii
marker
viru
base
partial
gene
delet
use
univers
vaccin
candid
differenti
genotyp
nevertheless
two
proofofprincipl
studi
de
lima
et
al
fang
et
al
exemplifi
potenti
ration
design
prrsv
marker
vaccin
may
develop
futur
central
role
dc
host
immun
indic
efficaci
vaccin
reli
effici
vaccin
interact
dc
dc
consid
target
design
novel
vaccin
enhanc
immunogen
vaccin
mccullough
summerfield
steinman
banchereau
develop
vaccin
deliveri
system
capabl
target
vaccin
antigen
agonist
dc
recogn
research
prioriti
advanc
immunolog
vaccin
discoveri
report
unit
stateseuropean
union
commiss
workshop
http
wwwtheaaviorgeuu
reportdoc
dctarget
immun
approach
valid
primat
murin
model
steinman
banchereau
exampl
tacken
et
al
demonstr
antibodymedi
target
antigen
human
dc
via
dcsign
effect
induc
antigenspecif
naiv
memori
tcell
respons
antigen
klh
crosslink
human
dcsign
antibodi
specif
bound
dcsign
rapidli
intern
transloc
lysosom
compart
target
effici
dc
higher
klh
alon
tacken
et
al
recent
revilla
et
al
demonstr
new
avenu
could
appli
pig
use
sialoadhesin
antigendeliveri
target
porcin
mddc
revilla
et
al
use
cell
pig
immun
antigen
mous
ig
respond
cell
mddc
without
express
compar
cell
prolif
respons
induc
mab
nontarget
control
mab
mab
bound
intern
rapidli
induc
recal
cell
prolif
respons
concentr
lower
control
mab
vitro
indic
target
antigen
effect
strategi
increas
immunogen
antigen
revilla
et
al
sinc
identifi
entri
receptor
prrsv
interact
heterodim
van
breedam
et
al
interest
see
whether
target
prrsv
antigen
directli
increas
vaccin
efficaci
potenti
dc
receptor
use
target
prrsv
antigen
may
includ
sever
porcin
tolllik
receptor
tlr
involv
prrsv
infect
chaung
et
al
sang
et
al
ctype
lectin
receptor
pdcsign
huang
et
al
plangerin
nfon
et
al
huang
meng
mention
induc
treg
appear
involv
inhibit
tcell
activ
prrsv
persist
infect
thu
may
obstacl
vaccin
prrsv
mlv
phenomenon
confirm
vivo
suppress
treg
induct
enhanc
vaccin
efficaci
import
develop
next
gener
prrsv
vaccin
base
attenu
viru
human
mous
model
mani
tregsdeplet
strategi
investig
exampl
report
deplet
natur
treg
use
mab
vaccin
vaccin
herp
simplex
viru
type
enhanc
cell
respons
viru
toka
et
al
administr
antibodi
immun
murin
leishmaniasi
vaccin
improv
vaccin
efficaci
stober
et
al
howev
approach
may
costprohibit
porcin
vaccin
futur
studi
need
identifi
viral
compon
associ
treg
induct
design
recombin
mlv
revers
genet
approach
abolish
potenti
risk
associ
treg
induct
mlv
gener
delet
essenti
factor
associ
pathogen
use
revers
genet
techniqu
coronavirus
delet
nsp
gene
shown
confer
attenu
natur
host
de
haan
et
al
haijema
et
al
ortego
et
al
major
role
mous
hepat
viru
mhv
sarscoronaviru
sarscov
counter
antivir
type
ifn
respons
inhibit
ifndepend
signal
downstream
event
wathelet
et
al
zust
et
al
mutant
mhv
contain
delet
gene
shown
grow
normal
vitro
strongli
attenu
mice
mutant
mhv
replic
convent
dc
macrophag
induc
robust
type
ifn
pdc
inocul
low
dose
mutant
mhv
result
elicit
strong
cytotox
cell
respons
protect
mice
homolog
heterolog
viru
challeng
zust
et
al
similarli
introduc
mutat
viral
gene
revers
genet
attenu
influenza
viru
mutant
gener
shown
attenu
differ
anim
model
due
induct
strong
type
interferon
respons
limit
replic
richt
garciasastr
describ
previous
sever
prrsv
nsp
involv
suppress
antivir
type
ifn
respons
beura
et
al
among
appear
strong
inhibitori
activ
beura
et
al
chen
et
al
howev
beura
et
al
suggest
sinc
multifunct
viral
protein
may
feasibl
structur
separ
proteinas
function
ifn
antagonist
function
therefor
mutant
viru
lack
antiifn
activ
may
rescu
beura
et
al
therefor
select
nsp
delet
target
may
appropri
search
suitabl
mlv
candid
nevertheless
genet
manipul
virus
restor
type
ifn
respons
may
provid
novel
strategi
develop
next
gener
prrsv
vaccin
swine
infertil
respiratori
syndrom
viru
isol
atcc
north
america
experiment
reproduct
diseas
gnotobiot
pig
j
vet
diagn
invest
coster
delputt
pl
nauwynck
hj
porcin
reproduct
respiratori
syndrom
virusinfect
alveolar
macrophag
contain
detect
level
viral
protein
plasma
membran
protect
antibodydepend
complementmedi
cell
lysi
j
gen
virol
pt
da
pb
dinh
px
ansari
ih
de
lima
osorio
fa
pattnaik
ak
minor
envelop
glycoprotein
porcin
reproduct
respiratori
syndrom
viru
interact
receptor
j
virol
de
haan
ca
master
ps
shen
x
weiss
rottier
pj
groupspecif
murin
coronaviru
gene
essenti
delet
revers
genet
attenu
natur
host
virolog
